Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CURIS INC | Director | Non Qualified Stock Option | 85K | $988K | $11.62 | Jan 31, 2022 | Direct |
Enliven Therapeutics, Inc. | Director | Common Stock | 31.2K | $605K | $19.40 | Apr 8, 2024 | Indirect |
Enliven Therapeutics, Inc. | Director | Common Stock | 14.8K | $286K | $19.40 | Apr 8, 2024 | Direct |
Oric Pharmaceuticals, Inc. | Director | Common Stock | 20.5K | $76.9K | $3.75 | Jun 3, 2024 | Direct |
Nurix Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $21.57 | Jul 17, 2024 | Direct |
Enliven Therapeutics, Inc. | Director | Stock Option (right to buy) | 37.9K | Apr 8, 2024 | Direct | ||
Oric Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 25.6K | Jun 12, 2024 | Direct | ||
Nurix Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 25K | May 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NRIX | Nurix Therapeutics, Inc. | Jul 17, 2024 | 1 | $0 | 4 | Jul 18, 2024 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Jun 3, 2024 | 2 | $76.9K | 4 | Jun 4, 2024 | Director |
NRIX | Nurix Therapeutics, Inc. | May 20, 2024 | 1 | $0 | 4 | May 20, 2024 | Director |
ELVN | Enliven Therapeutics, Inc. | Apr 8, 2024 | 1 | $0 | 4 | Apr 10, 2024 | Director |
ELVN | Enliven Therapeutics, Inc. | Apr 8, 2024 | 0 | $0 | 3 | Apr 10, 2024 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
NRIX | Nurix Therapeutics, Inc. | May 4, 2023 | 1 | $0 | 4 | May 4, 2023 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
NRIX | Nurix Therapeutics, Inc. | May 5, 2022 | 1 | $0 | 4 | May 6, 2022 | Director |
CRIS | CURIS INC | Jan 31, 2022 | 1 | $0 | 4 | Jan 31, 2022 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
NRIX | Nurix Therapeutics, Inc. | May 6, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |